Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1

被引：19

作者：

Groszek, Grazyna ^{[1
]}

Bednarski, Marek ^{[2
]}

Dybala, Malgorzata ^{[3
]}

Filipek, Barbara ^{[2
]}

机构：

[1] Rzeszow Univ Technol, Fac Chem, PL-35959 Rzeszow, Poland

[2] Jagiellonian Univ, Coll Med, Lab Pharmacol Screening, PL-30689 Krakow, Poland

[3] Jagiellonian Univ, Coll Med, Dept Pharmacobiol, PL-30689 Krakow, Poland

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 44卷 / 02期

关键词：

alpha(1)-; alpha(2)-; beta(1)-Adrenoceptor antagonist; Antiarrhythmic; hypotensive and spasmolytic activities; Synthesis; CARVEDILOL BLOCKS; CURRENTS;

D O I：

10.1016/j.ejmech.2008.05.019

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of (2RS)-1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol ((RS)-9) and its enantiomers has been described and tested for electrocardiographic, antiarrhythmic, hypotensive and spasmolytic activities as well as for alpha(1), alpha(2)- and beta(1)-adrenoceptors' binding affinities. All compounds significantly decrease systolic and diastolic blood pressure, and possess antiarrhythmic activity and affinity to alpha(1), alpha(2)- and beta(1)-adrenoceptors. The results suggest that the antiarrhythmic and hypotensive effects of these compounds are related to their adrenolytic but not spasmolytic properties. (c) 2008 Elsevier Masson SAS. All rights reserved.

引用

页码：809 / 817

页数：9

共 50 条

[31] Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Jie Cai
Ruirui Zhang
Crystallography Reports, 2022, 67 : 1183 - 1186
[32] Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Cai, Jie
Zhang, Ruirui
CRYSTALLOGRAPHY REPORTS, 2022, 67 (07) : 1183 - 1186
[33] Synthesis and positive inotropic evaluation of 1-(benzylamino)-3-(4,5-di-hydro[1,2,4]trizaolo[4,3-a]quinolin-7-yloxy)propan-2-ol derivatives
Ting Ting Li~a Ling Zhang~b Zhe Shan Quan~a Hai Bo Zhu~(b
Chinese Chemical Letters, 2009, 20 (02) : 175 - 177
[34] CRYSTAL AND MOLECULAR-STRUCTURES OF 1-(2-ISO BUTYLYL-CARBAMOYL PROPAN-2-YLAMINO) 3-(1-NAPHTHYLOXY)PROPAN-2-OL HYDROCHLORIDE (1) (C21H31N2O3CL) AND 1-(2-ISOBUTYLOXYCARBONYLO PROPAN-2-YLAMINO) 3-(1-NAPHTHYLOXY)PROPAN-2-OL HYDROCHLORIDE (2) (C21H30NO4CL)
WIECZOREK, MW
BUJACZ, GD
GALAS, E
ZJAWIONY, J
WOJCIECHOWSKA, A
JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1989, 19 (06): : 967 - 982
[35] Synthesis and positive inotropic evaluation of 1-(benzylamino)-3-(4,5-di-hydro[1,2,4]trizaolo[4,3-a]quinolin-7-yloxy)propan-2-ol derivatives
Li, Ting Ting
Zhang, Ling
Quan, Zhe Shan
Zhu, Hai Bo
Piao, Hu Ri
CHINESE CHEMICAL LETTERS, 2009, 20 (02) : 175 - 177
[36] PSILOCIN ANALOGS .1. SYNTHESIS OF 3-[2-(DIALKYLAMINO)ETHYL]-INDOL-4-OLS AND 3-[2-(CYCLOALKYLAMINO)ETHYL]INDOL-4-OLS
REPKE, DB
FERGUSON, WJ
BATES, DK
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1977, 14 (01) : 71 - 74
[37] SYNTHESES OF (S)-FENFLURAMINE FROM (R) OR (S)-1-[3-(TRIFLUOROMETHYL)PHENYL]PROPAN-2-OL
GOUMENT, B
DUHAMEL, L
MAUGE, R
BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE, 1993, 130 (04): : 450 - 458
[38] (E)-1-[2-(4-Chloro-2-nitrostyryl)-1-phenylsulfonyl-1H-indol-3-yl]-propan-1-one
Umadevi, M.
Saravanan, V.
Yamuna, R.
Mohanakrishnan, A. K.
Chakkaravarthi, G.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1784 - +
[39] (E)-1-[2-(4-Fluoro-2-nitrostyryl)-1-phenylsulfonyl-1H-indol-3-yl]propan-1-one
Umadevi, M.
Saravanan, V.
Yamuna, R.
Mohanakrishnan, A. K.
Chakkaravarthi, G.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : 01780 - +
[40] POLYMORPHISM AND CHIRALITY OF N-PHENYL-N'-[1-(3-(1-PHENYL-4-PIPERAZINO)PROPAN-2-OL)]UREA
BOSC, JJ
JARRY, C
LEGER, JM
NEGRIER, P
HAGET, Y
JOURNAL DE CHIMIE PHYSIQUE ET DE PHYSICO-CHIMIE BIOLOGIQUE, 1995, 92 (05) : 1066 - 1083

← 1 2 3 4 5 →